ZAZZI MAURIZIO | Elenco docenti

Clemente, T., Torkjazi, G., Capra, N., Gagliardini, R., Cattelan, A.M., Lolatto, R., et al. (2026). Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 81(1) [10.1093/jac/dkaf415]. - dettaglio
Amodeo, D., Marchi, S., Fiaschi, L., Raucci, L., Biba, C., Salvestroni, V., et al. (2025). Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm). APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 91(6) [10.1128/aem.00403-25]. - dettaglio
Clemente, T., Diotallevi, S., Minisci, D., Di Biagio, A., Lolatto, R., Attala, L., et al. (2025). Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkae465]. - dettaglio
Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M.V., Moschese, D., et al. (2025). Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(6), 1665-1672 [10.1093/jac/dkaf119]. - dettaglio
Papaioannu Borjesson, R., Diotallevi, S., Lolatto, R., Cenderello, G., Comi, L., Cascio, A., et al. (2025). Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(9), 2369-2374 [10.1093/jac/dkaf211]. - dettaglio

Tutte le pubblicazioni